iCAD to Present at SunTrust Robinson Humphrey's 37th Annual Institutional UnConference

NASHUA, N.H., April 11 iCAD, Inc.(Nasdaq: iCAD), an industry-leading provider of Computer-Aided Detection (CAD)solutions for the early identification of cancer, today announced that KenFerry, President and Chief Executive Officer and Darlene Deptula-Hicks,Executive Vice President and Chief Financial Officer, will be giving acorporate presentation at SunTrust Robinson Humphrey's 37th AnnualInstitutional UnConference on Wednesday, April 16, 2008 at 8:00 a.m. EDT atthe Ritz Carlton, Buckhead in Atlanta, Georgia.

SunTrust Robinson Humphrey's 37th Annual Institutional UnConferenceconnects company executives and management teams with investors, whereinvestors will have the opportunity to personally meet with management teamsin intimate one-on-one and small group meetings.

About iCAD, Inc.

iCAD, Inc. is an industry-leading provider of Computer-Aided Detection(CAD) solutions that enable healthcare professionals to better serve patientsby identifying pathologies and pinpointing cancer earlier. iCAD offers acomprehensive range of high-performance, upgradeable CAD systems for the high,mid and low volume mammography markets. iCAD is entrusted with the task ofearly cancer detection by more than 2,000 women's healthcare centersworldwide. For more information, call +1 877 iCADnow or visithttp://www.icadmed.com.

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn &

Associates at 212-838-3777 x6604 or via email at [email protected].

For iCAD Public Relations, contact Jill Testagrossa of Schwartz CommunicationsFor iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at [email protected].

SOURCE iCAD, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...